ProQR Therapeutics N.V. (PRQR)

ProQR Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	78.97	118.93	94.78	187.52	75.84	111.95
Cash & Short-Term Investments	96.15	118.93	94.78	187.52	75.84	111.95
Cash Growth	-25.21%	25.48%	-49.46%	147.27%	-32.26%	6.03%
Accounts Receivable	-	-	56.25	-	-	-
Other Receivables	4.55	1.27	0.98	0.82	0.8	1.19
Receivables	4.55	1.27	57.24	0.82	0.8	1.19
Prepaid Expenses	1.07	0.79	2.45	3.14	3.38	1.53
Total Current Assets	101.77	120.99	154.46	191.48	80.02	114.67
Property, Plant & Equipment	16.29	16.9	16.24	17.47	18.6	2.44
Long-Term Investments	-	-	0.62	0.63	0.11	0.43
Total Assets	118.05	137.88	171.32	209.58	98.73	117.54
Accounts Payable	0.03	1.54	0.39	0.19	0.22	0.45
Accrued Expenses	1.45	1.66	1.12	1.23	6.15	8.92
Current Portion of Long-Term Debt	4.44	-	2.5	4.77	1.14	0.34
Current Portion of Leases	1.68	1.61	1.39	1.53	1.26	0.51
Current Income Taxes Payable	-	-	-	-	-	0.06
Current Unearned Revenue	23.83	20.57	5.64	5.12	0.7	0.71
Other Current Liabilities	5.86	8.82	9.95	14.76	0.84	-
Total Current Liabilities	37.28	34.2	20.99	27.6	10.3	10.99
Long-Term Debt	-	4.29	4.27	39.32	16.19	12.71
Long-Term Leases	13.08	13.83	13.81	14.75	15.69	-
Long-Term Unearned Revenue	34.84	44.17	65.57	14.69	-	-
Total Liabilities	85.2	96.49	104.64	96.35	42.18	23.7
Common Stock	3.37	3.37	3.37	3	2.17	2.16
Additional Paid-In Capital	413.07	412.89	412.54	398.31	288.76	287.21
Retained Earnings	-410.55	-400.85	-379.11	-317.77	-257.75	-211.75
Comprensive Income & Other	26.97	25.98	30.26	30.3	23.92	16.7
Total Common Equity	32.85	41.39	67.07	113.83	57.09	94.33
Minority Interest	-	-	-0.38	-0.6	-0.55	-0.5
Shareholders' Equity	32.85	41.39	66.68	113.23	56.55	93.83
Total Liabilities & Equity	118.05	137.88	171.32	209.58	98.73	117.54
Total Debt	19.19	19.73	21.97	60.37	34.28	13.56
Net Cash (Debt)	76.96	99.19	72.8	127.15	41.56	98.39
Net Cash Growth	-28.09%	36.24%	-42.74%	205.94%	-57.76%	2.28%
Net Cash Per Share	0.95	1.22	1.02	1.98	0.83	2.40
Filing Date Shares Outstanding	81.68	81.35	80.82	71.29	50.2	49.75
Total Common Shares Outstanding	81.68	81.35	80.82	71.29	50.2	49.75
Working Capital	64.49	86.78	133.47	163.89	69.72	103.67
Book Value Per Share	0.40	0.51	0.83	1.60	1.14	1.90
Tangible Book Value	32.85	41.39	67.07	113.83	57.09	94.33
Tangible Book Value Per Share	0.40	0.51	0.83	1.60	1.14	1.90
Buildings	-	24.78	22.86	22.23	21.64	2.02
Machinery	-	5.91	4.91	4.25	3.63	2.98

Source: S&P Capital IQ. Standard template. Financial Sources.